European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease-Reference-Cited by-同舟云学术

European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease

Published:2022-12 Issue:12 Volume:28 Page:1578-1590
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Bartoletti Michele,Azap Ozlem,Barac Aleksandra,Bussini Linda,Ergonul Onder,Krause Robert,Martin-Quiros Alejandro,Paño-Pardo José Ramón,Power Nicholas,Sibani Marcella,Szabo Balint Gergely,Tsiodras Sotirios,Zollner-Schwetz Ines,Rodríguez-Baño Jesús

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference59 articles.

1. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention;Wu;JAMA,2020

2. ESCMID COVID-19 living guidelines: drug treatment and clinical management;Bartoletti;Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis,2022

3. A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab;Hentzien;Lancet Infect Dis,2022

4. Clinical management of COVID-19;World Health Organization,2020

5. Risk factors and risk groups,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines;Blood Reviews;2024-05

2. An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants;Frontiers in Cellular and Infection Microbiology;2023-12-14

3. What do clinicians mean by epidemics' preparedness;Clinical Microbiology and Infection;2023-06

4. Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia;Frontiers in Immunology;2023-05-23

5. Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy;BioDrugs;2023-05-06